Cascade Pharmaceuticals, Inc.
PrivateLast Round
Series D
Jun 10, 2026
Total Funding Raised
$224.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cascade Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers, develops, and commercializes innovative drugs targeting nuclear receptors and G protein-coupled receptors (GPCRs) for metabolic diseases and inflammation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cascade Pharmaceuticals, Inc. Comparables
Compare Cascade Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Terns Pharmaceutical | 78% | |
| Ascletis Pharma Inc. | 78% | |
| Viking Therapeutics, Inc. | 76% | |
Cascade Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 10, 2026 | ||||
| VC Round | Feb 11, 2026 | ||||
| Series C | Feb 10, 2026 | ||||
| Series B | Nov 28, 2025 | ||||
| Series A | Jun 5, 2025 | ||||
Series A | Aug 11, 2023 |
Cascade Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qingdao Guoxin Venture | VC Round, Series C |
| China Life Capital | VC Round, Series C |
| Shanghai Guotou Pioneer Private Equity Fund Management | Series C |
| Guokejiahe Fund | Series A |
| Lapam Capital | Series A |
| Jiuyou Capital | Early Funding |
| China Science and Technology Industry Investment Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2026
$72M round led by Zhongping Capital.
- Aug 11, 2023
$19.4M round with participation from Puhua Capital and PWC Capital.
Cascade Pharmaceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cascade Pharmaceuticals, Inc.'s valuation, stock price, and market status.